These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 29161205)
1. Imbalance Between Clinical and Pathologic Staging in the Updated American Joint Commission on Cancer Staging System for Human Papillomavirus-Positive Oropharyngeal Cancer. Fakhry C; Zevallos JP; Eisele DW J Clin Oncol; 2018 Jan; 36(3):217-219. PubMed ID: 29161205 [No Abstract] [Full Text] [Related]
2. Validation of the eighth edition American Joint Committee on Cancer staging system for human papillomavirus-associated oropharyngeal cancer. Cramer JD; Hicks KE; Rademaker AW; Patel UA; Samant S Head Neck; 2018 Mar; 40(3):457-466. PubMed ID: 28990257 [TBL] [Abstract][Full Text] [Related]
3. Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection. Yamashita Y; Ikegami T; Hirakawa H; Uehara T; Deng Z; Agena S; Uezato J; Kondo S; Kiyuna A; Maeda H; Suzuki M; Ganaha A Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):827-836. PubMed ID: 30594962 [TBL] [Abstract][Full Text] [Related]
4. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan. Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391 [TBL] [Abstract][Full Text] [Related]
5. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus. Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635 [TBL] [Abstract][Full Text] [Related]
6. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas. Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669 [TBL] [Abstract][Full Text] [Related]
7. Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus-Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center. Tsai CJ; McBride SM; Riaz N; Lee NY Pract Radiat Oncol; 2019 Mar; 9(2):98-101. PubMed ID: 30445229 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma. Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120 [TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus and Oropharyngeal Cancer. Tanaka TI; Alawi F Dent Clin North Am; 2018 Jan; 62(1):111-120. PubMed ID: 29126488 [TBL] [Abstract][Full Text] [Related]
10. American Joint Committee on Cancer eighth edition human papilloma virus positive oropharyngeal cancer staging system: Discordance between clinical and pathological staging systems. Hall SR; Neel GS; Chang BA; Howard BE; Nagel TH; Lott DG; Hayden RE; Zhang N; Hinni ML Head Neck; 2019 Aug; 41(8):2716-2723. PubMed ID: 30939209 [TBL] [Abstract][Full Text] [Related]
11. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS; Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003 [TBL] [Abstract][Full Text] [Related]
13. [HPV infection in head and neck squamous cell carcinoma (HNSCC). Highlights from ASCO 2010]. Ihloff AS; Knecht R; Tribius S HNO; 2010 Dec; 58(12):1163-7. PubMed ID: 20963389 [TBL] [Abstract][Full Text] [Related]
14. Staging of human papilloma virus related cancers of the oropharynx. Valero C; Shah JP J Surg Oncol; 2021 Nov; 124(6):931-934. PubMed ID: 34622962 [TBL] [Abstract][Full Text] [Related]
15. Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland. Wells LA; Junor EJ; Conn B; Pattle S; Cuschieri K J Clin Pathol; 2015 Oct; 68(10):849-52. PubMed ID: 26152733 [TBL] [Abstract][Full Text] [Related]
16. Spare the Knife When Retropharyngeal Lymph Nodes Are Present in Human Papillomavirus-Positive Oropharyngeal Cancer. Woody NM Int J Radiat Oncol Biol Phys; 2024 Sep; 120(1):13. PubMed ID: 39147432 [No Abstract] [Full Text] [Related]
17. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma. Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438 [TBL] [Abstract][Full Text] [Related]
18. HPV-related Oropharyngeal Carcinoma: A Review of Clinical and Pathologic Features With Emphasis on Updates in Clinical and Pathologic Staging. Buckley L; Jackett L; Clark J; Gupta R Adv Anat Pathol; 2018 May; 25(3):180-188. PubMed ID: 29394171 [TBL] [Abstract][Full Text] [Related]
19. Contemporary management of oropharyngeal cancer: anatomy and physiology of the oropharynx. Duvvuri U; Myers JN Curr Probl Surg; 2009 Feb; 46(2):119-84. PubMed ID: 19111679 [No Abstract] [Full Text] [Related]
20. Extended survival after chemotherapy and conservative radiotherapy for HPV-16 positive stage IVB oropharyngeal carcinoma. Ampil F; Chaudhery S; Devarakonda S; Mills G Acta Oncol; 2013 Aug; 52(6):1236-7. PubMed ID: 23421928 [No Abstract] [Full Text] [Related] [Next] [New Search]